All In MedTech

Device Trial Radar · NCT07937683

Comparison of Three Treatments for Myofascial Pain in Patients With Bruxism

Comparison of Medical Treatment Combined With an Occlusal Splint, Dry Needling, and Botox Injection in Patients With Bruxism

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

90

Actual

Start

May 1, 2021

Primary completion

Oct 14, 2022

Study completion Oct 14, 2022

Sponsor

Lead sponsor
Saglik Bilimleri UniversitesiAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study compared three treatments for myofascial pain in adults with clinical features of bruxism, such as tooth clenching or grinding. Myofascial pain is pain arising from muscles and sensitive areas within them. Ninety adults aged 18-60 years were randomly assigned to one of three groups: dry needling, botulinum toxin type A injections, or an occlusal splint worn at night together with medication. Dry needling involved inserting thin needles into sensitive points in the masseter muscles. Botulinum toxin injections were administered into the masseter muscles on both sides. The splint group received tizanidine and paracetamol for one month. The study assessed pain at rest and during jaw function, sensitivity to pressure, and mouth opening. Assessments were performed before treatment and at one day, one week, and one month after treatment. The purpose was to compare the short-term effects of these three treatments.

Conditions

  • Myofascial Pain - Dysfunction Syndrome of TMJ
  • Bruxism

Interventions

  • Dry needlingProcedure

    A single session of bilateral masseter dry needling was performed, targeting two or three active trigger points per muscle. Sterile, single-use acupuncture needles measuring 0.25 × 25 mm were inserted approximately 5 mm deep. Needles were briefly manipulated using rapid in-and-out movements and redirected within the trigger point region, then retained for 20 minutes.

  • Botulinium Toxin-ADrug

    Botulinum toxin type A (Botox, Allergan) was administered into both masseter muscles during a single session. A 100-unit vial was reconstituted with 2.5 mL of sterile 0.9% saline. Each masseter received 20 units distributed across three injection sites, for a total dose of 40 units per participant. The needle was inserted at approximately 45 degrees to the skin surface.

  • Occlusal SplintDevice

    A custom-made maxillary occlusal splint was fabricated from a 3-mm-thick polyvinyl acetate-polyethylene copolymer sheet using a vacuum-forming technique. Each splint was individually fitted and adjusted intraorally. Participants were instructed to wear the splint every night for one month.

  • TiZANidine 2 MG Oral CapsuleDrug

    Tizanidine 2 mg was administered orally every 12 hours for one month as adjunctive pharmacotherapy in the occlusal splint group.

  • Paracetamol (500 mg) tabletsDrug

    Paracetamol 500 mg was administered orally every 12 hours for one month as adjunctive pharmacotherapy in the occlusal splint group.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain Intensity at RestTime frame: Baseline (before treatment), Day 1, Week 1, and Month 1 after treatment.
  2. Pain Intensity During FunctionTime frame: Baseline (before treatment), Day 1, Week 1, and Month 1 after treatment.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Oral and Maxillofacial Surgery, Gülhane Faculty of Dentistry, University of Health Sciences

    Ankara, Ankara, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.